scholarly article | Q13442814 |
P356 | DOI | 10.1002/GPS.4917 |
P698 | PubMed publication ID | 29851173 |
P50 | author | Pascal Sienaert | Q83299251 |
Angela Carlier | Q88931325 | ||
P2093 | author name string | M P Wattjes | |
D Rhebergen | |||
M Vandenbulcke | |||
A Dols | |||
M L Stek | |||
E van Exel | |||
F Bouckaert | |||
M Ten Kate | |||
P2860 | cites work | Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts | Q71670103 |
A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities | Q73782396 | ||
“Mini-mental state” | Q25938989 | ||
A power primer | Q27861029 | ||
A New Depression Scale Designed to be Sensitive to Change | Q29614720 | ||
Structural MRI correlates of apathy symptoms in older persons without dementia: AGES-Reykjavik Study | Q33581449 | ||
Neuroanatomical correlates of apathy in late-life depression and antidepressant treatment response | Q33896511 | ||
Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis | Q33964983 | ||
Apathy is associated with white matter abnormalities in anterior, medial brain regions in persons with HIV infection | Q35000836 | ||
The efficacy and safety of ECT in depressed older adults: a literature review | Q35553727 | ||
Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial | Q35672140 | ||
The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia | Q35760152 | ||
Apathy and depression: separate factors in Parkinson's disease | Q35827021 | ||
Are the available apathy measures reliable and valid? A review of the psychometric evidence | Q37518104 | ||
Differential diagnosis and classification of apathy | Q38137420 | ||
Apathy in Older Persons With Depression: Course and Predictors: The NESDO Study | Q39966924 | ||
Contribution of white matter hyperintensities, medial temporal lobe atrophy and cortical atrophy on outcome, seven to twelve years after ECT in severely depressed geriatric patients | Q40724435 | ||
Low-grade inflammation differentiates between symptoms of apathy and depression in community-dwelling older individuals | Q41328792 | ||
Relationship Between Hippocampal Volume, Serum BDNF, and Depression Severity Following Electroconvulsive Therapy in Late-Life Depression | Q41654795 | ||
Association of vascular factors with apathy in community-dwelling elderly individuals | Q42651744 | ||
More insight into the concept of apathy: a multidisciplinary depression management program has different effects on depressive symptoms and apathy in nursing homes | Q43879622 | ||
Apathy is an independent risk factor for incident cardiovascular disease in the older individual: a population-based cohort study | Q44989611 | ||
Quality of life in community-dwelling older persons with apathy | Q45368024 | ||
Location of infarcts and apathy in ischemic stroke. | Q45781485 | ||
White matter hyperintensities, medial temporal lobe atrophy, cortical atrophy, and response to electroconvulsive therapy in severely depressed elderly patients | Q46453405 | ||
Apathy in older patients with type 2 diabetes | Q47779702 | ||
The longitudinal course of post-stroke apathy over five years | Q47955335 | ||
Early- and Late-Onset Depression in Late Life: A Prospective Study on Clinical and Structural Brain Characteristics and Response to Electroconvulsive Therapy | Q48038365 | ||
Vascular disease and apathy in old age. The Leiden 85-Plus Study | Q48393594 | ||
Is apathy in late-life depressive illness related to age-at-onset, cognitive function or vascular risk? | Q48497889 | ||
Clinical characteristics in subcortical ischemic white matter disease. | Q48557748 | ||
Location and progression of cerebral small-vessel disease and atrophy, and depressive symptom profiles: the Second Manifestations of ARTerial disease (SMART)-Medea study | Q48806618 | ||
Reliability, validity, and clinical correlates of apathy in Parkinson's disease | Q48852465 | ||
Reliability and validity of the apathy evaluation scale | Q48866734 | ||
Do people become more apathetic as they grow older? A longitudinal study in healthy individuals. | Q50716391 | ||
Apathy following cerebrovascular lesions. | Q51139357 | ||
Classifying depression by mental state signs. | Q52056885 | ||
Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging. | Q52893000 | ||
Group differences in the relationship between apathy and depression. | Q52919968 | ||
Syndromic validity of apathy in Alzheimer's disease. | Q53242142 | ||
Apathy: Why Care? | Q56228047 | ||
P577 | publication date | 2018-05-30 | |
P1433 | published in | International Journal of Geriatric Psychiatry | Q6051406 |
P1476 | title | The course of apathy in late-life depression treated with electroconvulsive therapy; a prospective cohort study |